ATE227024T1 - Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut - Google Patents

Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut

Info

Publication number
ATE227024T1
ATE227024T1 AT93918683T AT93918683T ATE227024T1 AT E227024 T1 ATE227024 T1 AT E227024T1 AT 93918683 T AT93918683 T AT 93918683T AT 93918683 T AT93918683 T AT 93918683T AT E227024 T1 ATE227024 T1 AT E227024T1
Authority
AT
Austria
Prior art keywords
trisomy
hcg
down syndrome
free beta
maternal blood
Prior art date
Application number
AT93918683T
Other languages
English (en)
Inventor
James N Macri
Original Assignee
James N Macri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James N Macri filed Critical James N Macri
Application granted granted Critical
Publication of ATE227024T1 publication Critical patent/ATE227024T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT93918683T 1992-08-07 1993-08-06 Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut ATE227024T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/925,844 US5324667A (en) 1989-01-17 1992-08-07 Method for detecting down sydrown by non-invasive maternal blood screening
PCT/US1993/007408 WO1994003804A1 (en) 1992-08-07 1993-08-06 Method and apparatus for detecting down syndrome by non-invasive maternal blood screening

Publications (1)

Publication Number Publication Date
ATE227024T1 true ATE227024T1 (de) 2002-11-15

Family

ID=25452336

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93918683T ATE227024T1 (de) 1992-08-07 1993-08-06 Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut

Country Status (9)

Country Link
US (1) US5324667A (de)
EP (1) EP0673508B1 (de)
JP (1) JP2877516B2 (de)
KR (1) KR0171451B1 (de)
AT (1) ATE227024T1 (de)
AU (1) AU689440B2 (de)
CA (1) CA2141668C (de)
DE (1) DE69332456D1 (de)
WO (1) WO1994003804A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674983A (en) * 1989-01-03 1997-10-07 The United States Of America As Represented By The Department Of Health And Human Services Natural human chorionic gonadotropin β-core molecule
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
US5594637A (en) * 1993-05-26 1997-01-14 Base Ten Systems, Inc. System and method for assessing medical risk
US5716853A (en) * 1995-07-07 1998-02-10 Chiron Diagnostics Corporation Prenatal down syndrome screening with assays specific for UGP
US6025149A (en) * 1995-07-07 2000-02-15 Yale University Urinary screening for down syndrome and other aneuploidies
US5606164A (en) * 1996-01-16 1997-02-25 Boehringer Mannheim Corporation Method and apparatus for biological fluid analyte concentration measurement using generalized distance outlier detection
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
US5888740A (en) * 1997-09-19 1999-03-30 Genaco Biomedical Products, Inc. Detection of aneuploidy and gene deletion by PCR-based gene- dose co-amplification of chromosome specific sequences with synthetic sequences with synthetic internal controls
US7314760B2 (en) * 2003-06-10 2008-01-01 Stc. Unm Biochemical test for identifying pregnancies with Down's syndrome fetus
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
EP1799861A2 (de) * 2004-09-20 2007-06-27 Proteogenix, Inc. Diagnose einer fötalen aneuploidie
WO2011144999A1 (en) 2010-05-17 2011-11-24 Sandra Reznik Plasma protein-a2 (papp-a2) as a marker for detecting risk of chromosomal abnormalities
GB201305317D0 (en) * 2013-03-22 2013-05-08 Iles Raymond K Prenatal screening for fetal abnormalities and disorders of pregnancy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016250A (en) * 1974-03-22 1977-04-05 Cornell Research Foundation, Inc. Method for testing for pregnancy
US4123224A (en) * 1975-12-17 1978-10-31 American Home Products Corporation Diagnostic test device
JPS54126723A (en) * 1978-03-23 1979-10-02 Teikoku Hormone Mfg Co Ltd Preparation of specific hcg and specific anti-hcg-beta-subunit antibody
US4565687A (en) * 1981-11-16 1986-01-21 The Reagents Of The University Of Michigan Monoclonal antibodies specific for the unbound β subunit of human chorionic gonadotropin
GR850899B (de) * 1984-04-12 1985-11-25 Gen Hospital Corp
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
EP0362294B1 (de) * 1987-07-09 1993-06-30 3i RESEARCH EXPLOITATION LIMITED Pränatales screening für downs-syndrom
US5037305A (en) * 1988-11-16 1991-08-06 Vivigen, Inc. Graphic method for reporting risk to a patient
ATE252240T1 (de) * 1989-01-17 2003-11-15 Jn Macri Technologies Llc Inc Einrichtung zum nachweis vom down syndrom durch nichtinvasive siebtestung des mütterlichen blutes

Also Published As

Publication number Publication date
EP0673508A4 (de) 1997-06-25
CA2141668A1 (en) 1994-02-17
CA2141668C (en) 2007-01-02
WO1994003804A1 (en) 1994-02-17
DE69332456D1 (de) 2002-12-05
JPH08503067A (ja) 1996-04-02
AU4804393A (en) 1994-03-03
EP0673508A1 (de) 1995-09-27
US5324667A (en) 1994-06-28
AU689440B2 (en) 1998-04-02
JP2877516B2 (ja) 1999-03-31
KR0171451B1 (ko) 1999-05-01
EP0673508B1 (de) 2002-10-30

Similar Documents

Publication Publication Date Title
ATE230488T1 (de) Screeningverfahren für das down-syndrom unter verwendung von getrockneten blutproben
ATE227024T1 (de) Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut
DE69931910D1 (en) Pränatales screening für downs-syndrom
IL129382A0 (en) Use of anti-embryonic hemoglobin antibodies to identify fetal cells
WO2002033120A3 (en) Non-invasive prenatal monitoring
PT923730E (pt) Rastreio pré-natal da síndrome de down utilizando gonadotrofina hiperglicosilada
Spencer et al. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome
ATE252240T1 (de) Einrichtung zum nachweis vom down syndrom durch nichtinvasive siebtestung des mütterlichen blutes
Christiansen et al. An increase in cost‐effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing
US5100806A (en) Method for detecting Edwards syndrome
DE69525400D1 (de) Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten
DK115489D0 (da) Foerfoedselscreening for down's syndrom
RU93036133A (ru) Способ определения состояния плода
Fuhrmann et al. First‐trimester alpha‐fetoprotein screening for Down syndrome
DE69418759D1 (de) Vorgeburtliche Überprüfung von Missbildungen der Chromosomen
Evans et al. Standardization of methods reduces variability: explanation for historical discrepancies in biochemical screening
Christiansen et al. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome
Spencer et al. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome/Author's reply
ATE240525T1 (de) Pränatales testverfahren für down-syndrom
JP3440138B2 (ja) 染色体異常について妊娠期間中にスクリーニングするための方法および装置
Erdemli et al. Is median value of Double Screening Test regional?/İkili Tarama Testi medyan değerleri bölgesel midir?
Bohm et al. On a possible early identification procedure for babies at high risk for autistic spectrum disorder
Feldman et al. 2nd-trimester maternal serum marker results are not altered by delayed analysis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties